Get Our FREE Newsletter

Sign Up

Analysts Estimate Emergent Biosolutions (EBS) to Report a Decline in Earnings: What to Look Out for

Spread the love

Wall Street expects a year-over-year decline in earnings on higher revenues when Emergent Biosolutions (EBS) reports results for the quarter ended June 2021. While this widely-known consensus outlook is important in gauging the company’s earnings picture, a powerful facto

This post was originally published on this site